What a great success story!

Herbst Kinsky advises the founder team Alexander Belcredi and Lorenzo Corsini and the other shareholders on the sale of PhagoMed to BioNTech SE.

The team around our lead partner Christoph Wildmoser wishes the founders and the company continuing success for the future.